Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 59
Filtrar
Más filtros

Medicinas Complementárias
Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Animal ; 14(1): 50-58, 2020 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-31280736

RESUMEN

The use of additives such as ractopamine (Rac) in pregnant sows during early-mid pregnancy is an alternative to increase foetal and progeny growth and development. However, Rac supplementation in finishing pigs can lead to behavioural and physiological changes similar to the typical stress responses. The objective of this study was to evaluate the effects of dietary supplementation with Rac in pregnant sows from day 25 to 50 of gestation (pre-hyperplastic stage) on piglet's vitality, blood parameters, number, diameter and perimeter of muscle fibres in semitendinosus muscle and developmental characteristics of piglets at birth to weaning. Forty-one hybrid sows were divided into three dietary treatments: (1) control diet without Rac (control), (2) addition of 10 mg/kg of Rac (Rac10) and (3) addition of 20 mg/kg of Rac (Rac20). Higher numbers of low-vitality piglets (P<0.05) were observed in Rac-fed sows, regardless of dose, compared with the control group. Very low-density lipoprotein levels were lower in the Rac10 group when compared with the Rac20 group at day 21. Haematocrit was greater, and the mean corpuscular haemoglobin concentration was lower in piglets from Rac-fed sows. No significant statistical differences were detected regarding piglets body weight, average daily gain, blood gasometry, complete blood count and muscle fibre measurements in semitendinosus muscle. The use of Rac in pregnant sows reduced the vitality parameters of piglets but did not improve the performance from birth until weaning and did not negatively influence the haematological parameter and lipid metabolism.


Asunto(s)
Fenetilaminas/metabolismo , Sus scrofa/fisiología , Alimentación Animal/análisis , Animales , Animales Recién Nacidos/sangre , Animales Recién Nacidos/fisiología , Dieta/veterinaria , Suplementos Dietéticos/análisis , Femenino , Fenetilaminas/administración & dosificación , Embarazo , Sus scrofa/sangre
2.
Eur J Pharmacol ; 859: 172515, 2019 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-31265842

RESUMEN

Preworkout supplements ("boosters") are used to enhance physical and mental performance during workouts. These products may contain various chemical substances with undefined pharmacological activity. We investigated whether substances that are contained in commercially available athletic multiple-ingredient preworkout supplements exert amphetamine-type activity at norepinephrine, dopamine, and serotonin transporters (NET, DAT, and SERT, respectively). We assessed the in vitro monoamine transporter inhibition potencies of the substances using human embryonic kidney 293 cells that expressed the human NET, DAT, and SERT. The phenethylamines ß-phenethylamine, N-methylphenethylamine, ß-methylphenethylamine, N-benzylphenethylamine, N-methyl-ß-methylphenethylamine, and methylsynephrine inhibited the NET and less potently the DAT similarly to D-amphetamine. ß-phenethylamine was the most potent, with IC50 values of 0.05 and 1.8 µM at the NET and DAT, respectively. These IC50 values were comparable to D-amphetamine (IC50 = 0.09 and 1.3 µM, respectively). The alkylamines 1,3-dimethylbutylamine and 1,3-dimethylamylamine blocked the NET but not the DAT. Most of the phenethylamines interacted with trace amine-associated receptor 1, serotonin 5-hydroxytryptamine-1A receptor, and adrenergic α1A and α2A receptors at submicromolar concentrations. None of the compounds blocked the SERT. In conclusion, products that are used by athletes may contain substances with mainly noradrenergic amphetamine-type properties.


Asunto(s)
Ejercicio Físico/fisiología , Sustancias para Mejorar el Rendimiento/farmacología , Monoaminas Biogénicas/metabolismo , Transporte Biológico/efectos de los fármacos , Proteínas de Transporte de Catecolaminas en la Membrana Plasmática/metabolismo , Suplementos Dietéticos , Células HEK293 , Humanos , Sustancias para Mejorar el Rendimiento/metabolismo , Fenetilaminas/metabolismo , Fenetilaminas/farmacología
3.
Biomed Pharmacother ; 111: 1393-1398, 2019 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-30841454

RESUMEN

BACKGROUND: Citri Reticulatae Pericarpium (CRP), Aurantii Fructus Immaturus (AFI) and Aurantii Fructus (AF) are all important Citrus species used in traditional Chinese medicines (TCMs) for the treatment of gastrointestinal disorders. Although they have been used since ancient times and are still in use today, the mechanistic basis for their regulation of adrenergic receptors (ARs) is still not clear. PURPOSE: In this study, we aimed to determine the active components and mechanisms of action of CRP, AFI and AF in treating gastrointestinal disorders related to ARs. METHODS: First, the phenethylamine alkaloid components of CRP, AFI and AF were identified and compared across 30 samples of three Citrus species by UPLC-Q/TOF-MS in combination with content difference analysis. Second, the effect of the main active alkaloid component on AR-based gastrointestinal disorders was investigated by an in vivo small intestinal propulsive test and an in vitro relaxing small intestinal smooth muscle activity test. The mechanism of AR regulation of the active alkaloid was further studied by evaluating its effect on relaxing small intestinal smooth muscle in the presence of an inhibitor. Lastly, the enzymes, which played an important role in epinephrine synthesis and AR regulation, were detected by immunohistochemistry. RESULTS: Three phenethylamine AR regulators (N-methyltyramine, synephrine and hordenine) in CRP, AFI and AF were characterized. It was found that N-methyltyramine could relax mouse small intestinal smooth muscle and inhibit small intestinal propulsion. The effect of N-methyltyramine on relaxing small intestinal smooth muscle could be inhibited by a-methyl-l-tyrosine. The enzymes related epinephrine synthesis and AR function were found in the mouse small intestine. The biotransformation process that converts N-methyltyramine to epinephrine was determined. CONCLUSION: The treatment of gastrointestinal disorders of CRP, AFI and AF is associated with their alkaloid component N-methyltyramine via the regulation of ARs, and the mechanism is considered to be the biotransformation of N-methyltyramine to epinephrine by serial synthase, which takes place at the nerves cells in small intestine.


Asunto(s)
Epinefrina/metabolismo , Enfermedades Gastrointestinales/tratamiento farmacológico , Enfermedades Gastrointestinales/metabolismo , Receptores Adrenérgicos/metabolismo , Tiramina/análogos & derivados , Alcaloides/farmacología , Animales , Citrus/química , Medicamentos Herbarios Chinos/farmacología , Frutas/química , Intestino Delgado/efectos de los fármacos , Intestino Delgado/metabolismo , Masculino , Ratones , Músculo Liso/efectos de los fármacos , Músculo Liso/metabolismo , Fenetilaminas/metabolismo , Tiramina/farmacología
4.
Molecules ; 24(4)2019 Feb 25.
Artículo en Inglés | MEDLINE | ID: mdl-30823561

RESUMEN

25B-NBF, 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-fluorobenzyl)ethanamine, is a new psychoactive substance classified as a phenethylamine. It is a potent agonist of the 5-hydroxytryptamine receptor, but little is known about its metabolism and elimination properties since it was discovered. To aid 25B-NBF abuse screening, the metabolic characteristics of 25B-NBF were investigated in human hepatocytes and human cDNA-expressed cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT) enzymes using liquid chromatography⁻high resolution mass spectrometry. At a hepatic extraction ratio of 0.80, 25B-NBF was extensively metabolized into 33 metabolites via hydroxylation, O-demethylation, bis-O-demethylation, N-debenzylation, glucuronidation, sulfation, and acetylation after incubation with pooled human hepatocytes. The metabolism of 25B-NBF was catalyzed by CYP1A1, CYP1A2, CYP2B6, CYP2C9, CYP2C19, CYP2D6, CYP2J2, CYP3A4, and UGT2B7 enzymes. Based on these results, it is necessary to develop a bioanalytical method for the determination of not only 25B-NBF but also its metabolites in biological samples for the screening of 25B-NBF abuse.


Asunto(s)
Compuestos de Bencilo/química , Compuestos de Bencilo/metabolismo , Etilaminas/química , Etilaminas/metabolismo , Hepatocitos/metabolismo , Fenetilaminas/metabolismo , Antagonistas de la Serotonina/metabolismo , Biocatálisis , Cromatografía Liquida , Sistema Enzimático del Citocromo P-450/genética , Sistema Enzimático del Citocromo P-450/metabolismo , Evaluación Preclínica de Medicamentos , Expresión Génica , Glucuronosiltransferasa/genética , Glucuronosiltransferasa/metabolismo , Humanos , Estructura Molecular , Receptores de Serotonina/metabolismo , Relación Estructura-Actividad , Espectrometría de Masas en Tándem
5.
Brain Res Bull ; 147: 47-57, 2019 04.
Artículo en Inglés | MEDLINE | ID: mdl-30771409

RESUMEN

Hearing loss and cognitive decline are commonly associated with aging and morbidity. Present clinical interest lies in whether peripheral hearing loss promotes cognitive decline and if prophylaxis with selective adenosine receptor agonist CGS21680 effectively mitigates the adverse effects. In the current study, male Sprague Dawley rats weighing 200-250 g m were randomly allocated into three groups: Group 1) rats exposed to 100 dB SPL white noise, 2 h a day for 15 consecutive days, 2) rats supplemented with an adenosine receptor agonist, CGS21680 at 100 µg/kg/day prior to noise exposure and 3) unexposed control rats. Baseline hearing and cognition assessed by auditory brainstem response (ABR) and water maze respectively was undertaken for all the groups. Phalloidin stain and synaptic ribbons count in cochlea, and, Ki67, DCX and NeuN in hippocampus were observed by immunohistochemistry. It was inferred that noise exposed rats showed elevated thresholds of ABR and poorer performances in spatial working memory when compared with controls. On the contrary, CGS21680 administered group exhibited improved ABR and cognitive functions with shorter mean latency and path-length to reach the platform, significant reduction in the noise induced loss of synaptic ribbons count and increased number of Ki67 and doublecortin (DCX) positive cells compared to their noise exposed counterparts. Pharmacologic intervention with selective A2A receptor agonist CGS21680 provided adequate protection from noise by effectively maintaining hearing threshold levels, cell viability in cochlea and hippocampus & functional/intact reference memory.


Asunto(s)
Adenosina/análogos & derivados , Pérdida Auditiva Provocada por Ruido/tratamiento farmacológico , Neurogénesis/efectos de los fármacos , Fenetilaminas/farmacología , Estimulación Acústica , Adenosina/metabolismo , Adenosina/farmacología , Agonistas del Receptor de Adenosina A2/farmacología , Animales , Cóclea , Disfunción Cognitiva/tratamiento farmacológico , Disfunción Cognitiva/fisiopatología , Proteína Doblecortina , Potenciales Evocados Auditivos del Tronco Encefálico/efectos de los fármacos , Pérdida Auditiva/tratamiento farmacológico , Pérdida Auditiva/fisiopatología , Pérdida Auditiva Provocada por Ruido/fisiopatología , Hipocampo , Masculino , Memoria , Neurogénesis/fisiología , Ruido/efectos adversos , Fenetilaminas/metabolismo , Ratas , Ratas Sprague-Dawley , Receptor de Adenosina A2A/metabolismo
6.
Microb Cell Fact ; 16(1): 3, 2017 Jan 03.
Artículo en Inglés | MEDLINE | ID: mdl-28049528

RESUMEN

BACKGROUND: Whole-cell biocatalysis based on metabolically active baker's yeast with engineered transamination activity can be used to generate molecules carrying a chiral amine moiety. A prerequisite is though to express efficient ω-transaminases and to reach sufficient intracellular precursor levels. RESULTS: Herein, the efficiency of three different ω-transaminases originating from Capsicum chinense, Chromobacterium violaceum, and Ochrobactrum anthropi was compared for whole-cell catalyzed kinetic resolution of racemic 1-phenylethylamine to (R)-1-phenylethylamine. The gene from the most promising candidate, C. violaceum ω-transaminase (CV-TA), was expressed in a strain lacking pyruvate decarboxylase activity, which thereby accumulate the co-substrate pyruvate during glucose assimilation. However, the conversion increased only slightly under the applied reaction conditions. In parallel, the effect of increasing the intracellular pyridoxal-5'-phosphate (PLP) level by omission of thiamine during cultivation was investigated. It was found that without thiamine, PLP supplementation was redundant to keep high in vivo transamination activity. Furthermore, higher reaction rates were achieved using a strain containing several copies of CV-TA gene, highlighting the necessity to also increase the intracellular transaminase level. At last, this strain was also investigated for asymmetric whole-cell bioconversion of acetophenone to (S)-1-phenylethylamine using L-alanine as amine donor. Although functionality could be demonstrated, the activity was extremely low indicating that the native co-product removal system was unable to drive the reaction towards the amine under the applied reaction conditions. CONCLUSIONS: Altogether, our results demonstrate that (R)-1-phenylethylamine with >99% ee can be obtained via kinetic resolution at concentrations above 25 mM racemic substrate with glucose as sole co-substrate when combining appropriate genetic and process engineering approaches. Furthermore, the engineered yeast strain with highest transaminase activity was also shown to be operational as whole-cell catalyst for the production of (S)-1-phenylethylamine via asymmetric transamination of acetophenone, albeit with very low conversion.


Asunto(s)
Ingeniería Metabólica/métodos , Saccharomyces cerevisiae/enzimología , Saccharomyces cerevisiae/genética , Transaminasas/metabolismo , Capsicum/enzimología , Capsicum/genética , Chromobacterium/enzimología , Chromobacterium/genética , Ochrobactrum anthropi/enzimología , Ochrobactrum anthropi/genética , Fenetilaminas/metabolismo , Saccharomyces cerevisiae/metabolismo , Estereoisomerismo , Transaminasas/biosíntesis , Transaminasas/genética
7.
J Agric Food Chem ; 63(39): 8694-704, 2015 Oct 07.
Artículo en Inglés | MEDLINE | ID: mdl-26375852

RESUMEN

Sensory screening of a series of naturally occurring N-cinnamoyl derivatives of substituted phenethylamines revealed that rubemamine (9, from Chenopodium album) and rubescenamine (10, from Zanthoxylum rubsecens) elicit strong intrinsic umami taste in water at 50 and 10 ppm, respectively. Sensory tests in glutamate- and nucleotide-containing bases showed that the compounds influence the whole flavor profile of savory formulations. Both rubemamine (9) and rubescenamine (10) at 10-100 ppm dose-dependently positively modulated the umami taste of MSG (0.17-0.22%) up to threefold. Among the investigated amides, only rubemamine (9) and rubescenamine (10) are able to directly activate the TAS1R1-TAS1R3 umami taste receptor. Moreover, both compounds also synergistically modulated the activation of TAS1R1-TAS1R3 by MSG. Most remarkably, rubemamine (9) was able to further positively modulate the IMP-enhanced TAS1R1-TAS1R3 response to MSG ∼ 1.8-fold. Finally, armatamide (11), zanthosinamide (13), and dioxamine (14), which lack intrinsic umami taste in vivo and direct receptor response in vitro, also positively modulated receptor activation by MSG about twofold and the IMP-enhanced MSG-induced TAS1R1-TAS1R3 responses approximately by 50%. In sensory experiments, dioxamine (14) at 25 ppm in combination with 0.17% MSG exhibited a sensory equivalent to 0.37% MSG.


Asunto(s)
Chenopodium album/química , Aromatizantes/química , Fenetilaminas/química , Extractos Vegetales/química , Glutamato de Sodio/metabolismo , Zanthoxylum/química , Aromatizantes/síntesis química , Aromatizantes/metabolismo , Humanos , Estructura Molecular , Fenetilaminas/síntesis química , Fenetilaminas/metabolismo , Extractos Vegetales/síntesis química , Extractos Vegetales/metabolismo , Receptores Acoplados a Proteínas G/metabolismo , Gusto
8.
Acta Biochim Pol ; 62(2): 235-40, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25856561

RESUMEN

Methyl jasmonate has a strong effect on secondary metabolizm in plants, by stimulating the biosynthesis a number of phenolic compounds and alkaloids. Common buckwheat (Fagopyrum esculentum Moench) is an important source of biologically active compounds. This research focuses on the detection and quantification of 2-phenylethylamine and its possible metabolites in the cotyledons, hypocotyl and roots of common buckwheat seedlings treated with methyl jasmonate. In cotyledons of buckwheat sprouts, only traces of 2-phenylethylamine were found, while in the hypocotyl and roots its concentration was about 150 and 1000-times higher, respectively. Treatment with methyl jasmonate resulted in a 4-fold increase of the 2-phenylethylamine level in the cotyledons of 7-day buckwheat seedlings, and an 11-fold and 5-fold increase in hypocotyl and roots, respectively. Methyl jasmonate treatment led also to about 4-fold increase of phenylacetic acid content in all examined seedling organs, but did not affect the 2-phenylethanol level in cotyledons, and slightly enhanced in hypocotyl and roots. It has been suggested that 2-phenylethylamine is a substrate for the biosynthesis of phenylacetic acid and 2-phenylethanol, as well as cinnamoyl 2-phenethylamide. In organs of buckwheat seedling treated with methyl jasmonate, higher amounts of aromatic amino acid transaminase mRNA were found. The enzyme can be involved in the synthesis of phenylpyruvic acid, but the presence of this compound could not be confirmed in any of the examined organs of common buckwheat seedling.


Asunto(s)
Acetatos/farmacología , Ciclopentanos/farmacología , Fagopyrum/metabolismo , Oxilipinas/farmacología , Fenetilaminas/metabolismo , Fenilacetatos/metabolismo , Alcohol Feniletílico/metabolismo , Enzimas/genética , Enzimas/metabolismo , Fagopyrum/efectos de los fármacos , Fagopyrum/genética , Regulación de la Expresión Génica de las Plantas/efectos de los fármacos , Plantones/efectos de los fármacos , Plantones/metabolismo
9.
Chem Biol Drug Des ; 84(6): 712-20, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-24894156

RESUMEN

Trace Amine-Associated Receptor 1 (TAAR1) is a G protein-coupled receptor that is expressed in brain and periphery and responds to a class of compounds called trace amines, such as ß-phenylethylamine (ß-PEA), tyramine, tryptamine, octopamine. The receptor is known to have a very rich pharmacology and could be also activated by different classes of compounds, including dopaminergic, adrenergic and serotonergic ligands. It is expected that targeting hTAAR1 could provide a novel pharmacological approach for several human disorders, such as schizophrenia, depression, attention deficit hyperactivity disorder, Parkinson's disease and metabolic diseases. Only recently, a small number of selective hTAAR1 agonists (among which RO5166017 and T1 AM) and antagonist (EPPTB), have been reported in literature. With the aim to identify new molecular entities able to act as ligands for this target, we used an homology model for the hTAAR1 and performed a virtual screening procedure on an in-house database of compounds. A number of interesting molecules were selected and by testing them in an in vitro assay we found several agonists and one antagonist, with activities in the low micromolar range. These compounds could represent the starting point for the development of more potent and selective TAAR1 ligands.


Asunto(s)
Receptores Acoplados a Proteínas G/agonistas , Sitios de Unión , Bases de Datos de Compuestos Químicos , Evaluación Preclínica de Medicamentos , Transferencia Resonante de Energía de Fluorescencia , Células HEK293 , Humanos , Ligandos , Simulación del Acoplamiento Molecular , Oxazoles/química , Oxazoles/metabolismo , Fenetilaminas/química , Fenetilaminas/metabolismo , Unión Proteica , Estructura Terciaria de Proteína , Receptores Acoplados a Proteínas G/antagonistas & inhibidores , Receptores Acoplados a Proteínas G/metabolismo
10.
J Anim Sci ; 92(1): 376-83, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24243905

RESUMEN

The effect of ractopamine hydrochloride (RH) and zilpaterol hydrochloride (ZH) on slice shear force (SSF) and sensory characteristics of beef from calf-fed Holstein steers was evaluated. All steers were implanted with a progesterone (100 mg) plus estradiol benzoate (10 mg) implant followed by a terminal trenbolone acetate (200 mg) plus estradiol (40 mg) implant. Steers were blocked by weight into pens (n = 32) randomly assigned to 1 of 4 treatments: control, RH fed at 300 mg·steer(-1)·d(-1) (RH 300) or RH fed at 400 mg·steer(-1)·d(-1)(RH 400) for the final 31 d of finishing, or ZH fed at 6.8 g/t for 21 d with a 5-d withdrawal before harvest. Fourteen carcasses were randomly selected from each pen, and two LM samples (1 per side) were excised and aged either 14 or 21 d before SSF testing. For trained panel evaluation, two steaks were collected from each of 60 low Choice strip loins (20 each from control, RH 300, and ZH treatments) and aged either 14 or 21 d. Steers fed RH and ZH produced steaks with SSF values that were 9% to 25% higher than controls. No difference in SSF was detected between the two levels of RH (P > 0.05). Compared to controls, the probability of steaks aged 14 d failing to meet SSF requirements to be certified tender (SSF < 20 kg) was increased 0.15, 0.17, and 0.26 in steers fed RH 300, RH 400, and ZH, respectively. Compared to controls, the probability of steaks aged 21 d having SSF values >20 kg was increased 0.03, 0.08, and 0.16 in steers fed RH 300, RH 400, and ZH, respectively. Steaks from Select carcasses of steers fed ZH aged 21 d postmortem had double the probability (0.39 vs. 0.17) of having SSF values >20 kg compared to steaks from steers fed either level of RH (P < 0.05). This difference tended to be identical in steaks from Select carcasses 14 d postmortem (0.50 vs. 0.33; P = 0.11); however, no difference was found in low Choice samples at 14 or 21 d postmortem. Trained panelists rated steaks aged 14 d from steers fed ZH lower for overall tenderness and flavor compared to controls (P < 0.05); however, no difference was found between controls and those fed RH 300. Steaks from steers fed ZH aged 21 d were rated lower for overall tenderness and juiciness compared to controls and those from steers fed RH 300 (P < 0.05). This study suggests RH and ZH negatively impact sensory attributes of beef from calf-fed Holstein steers.


Asunto(s)
Agonistas Adrenérgicos beta/metabolismo , Composición Corporal/efectos de los fármacos , Bovinos/fisiología , Carne/análisis , Músculos Paraespinales/efectos de los fármacos , Fenetilaminas/metabolismo , Compuestos de Trimetilsililo/metabolismo , Agonistas Adrenérgicos beta/administración & dosificación , Alimentación Animal/análisis , Animales , Dieta/veterinaria , Suplementos Dietéticos/análisis , Implantes de Medicamentos/administración & dosificación , Implantes de Medicamentos/farmacología , Estradiol/administración & dosificación , Estradiol/análogos & derivados , Estradiol/farmacología , Masculino , Músculos Paraespinales/fisiología , Fenetilaminas/administración & dosificación , Progesterona/administración & dosificación , Progesterona/farmacología , Resistencia al Corte , Acetato de Trembolona/administración & dosificación , Acetato de Trembolona/farmacología , Compuestos de Trimetilsililo/administración & dosificación
11.
J Anim Sci ; 92(1): 369-75, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24243909

RESUMEN

Effects of ractopamine hydrochloride (RH) and zilpaterol hydrochloride (ZH) on saleable yield of carcass sides from calf-fed Holstein steers were evaluated using steers implanted with a progesterone (100 mg) plus estradiol benzoate (10 mg) implant followed by a terminal trenbolone acetate (200 mg) plus estradiol (40 mg) implant. Steers were blocked by weight into pens (n = 32) randomly assigned to one of four treatments: control, RH fed at 300 mg•steer(-1)/d(-1) (RH 300) or RH fed at 400 mg•steer(-1)/d(-1) (RH 400) the final 31 d of finishing, and ZH fed at 60 to 90 mg•steer(-1)/d(-1) (7.56 g/ton on a 100% DM basis) for 21 d with a 5 d withdrawal before harvest. Eight to nine carcass sides were randomly selected from each pen; carcass sides with excessive hide pulls, fat pulls or bruises were avoided. Cutout data were collected within a commercial facility using plant personnel to fabricate sides at a rate of one every 3 to 4 min into items typically merchandised by the facility. All lean, fat and bone were weighed and summed back to total chilled side weight with a sensitivity of ± 2% to be included in the data set. Compared to controls, ß-agonists increased saleable yield of whole-muscle cuts by 0.61%, 0.86% and 1.95% for RH 300, RH 400 and ZH, respectively (P < 0.05). Percent fat was less in carcasses from the ZH treatment compared to controls (P < 0.05); however, this difference was not observed between RH treatments and controls (P > 0.05). Percent bone was less in the ZH treatment due to increased muscle (P < 0.05). The percent of chilled side weight comprised of trimmings was unchanged between treatments, but on a 100% lean basis, RH 400 and ZH increased trim yields (P < 0.05). Analysis of saleable yield by primal showed a fundamental shift in growth and development. Beta-agonists caused a shift in proportion of saleable yield within individual primals, with a greater portion produced from the hindquarter relative to the forequarter, specifically in those muscles of the round (P < 0.05). Beta-agonists increased saleable yield, but these effects were not constant between all major primals. The cutout value gained by packers as a result of ß-agonist use may be influenced more by reduced fatness and increased absolute weight if musculature is primarily increased in the lower priced cuts of the carcass.


Asunto(s)
Agonistas Adrenérgicos beta/metabolismo , Composición Corporal/efectos de los fármacos , Bovinos/fisiología , Carne/análisis , Músculo Esquelético/efectos de los fármacos , Fenetilaminas/metabolismo , Compuestos de Trimetilsililo/metabolismo , Agonistas Adrenérgicos beta/administración & dosificación , Alimentación Animal/análisis , Animales , Dieta/veterinaria , Suplementos Dietéticos/análisis , Implantes de Medicamentos/administración & dosificación , Implantes de Medicamentos/farmacología , Estradiol/administración & dosificación , Estradiol/análogos & derivados , Estradiol/farmacología , Masculino , Fenetilaminas/administración & dosificación , Progesterona/administración & dosificación , Progesterona/farmacología , Acetato de Trembolona/administración & dosificación , Acetato de Trembolona/farmacología , Compuestos de Trimetilsililo/administración & dosificación
12.
J Anim Sci ; 91(9): 4426-39, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23851996

RESUMEN

Two experiments (384 pigs; C22 × L326; PIC) were conducted to determine the interactive effect of dietary L-carnitine and ractopamine HCl (RAC) on the metabolic response of pigs to handling. Experiments were arranged as split-split plots with handling as the main plot and diets as subplots (4 pens per treatment). Dietary L-carnitine (0 or 50 mg/kg) was fed from 36.0 kg to the end of the experiments (118 kg), and RAC (0 or 20 mg/kg) was fed the last 4 wk of each experiment. At the end of each experiment, 4 pigs per pen were assigned to 1 of 2 handling treatments. Gently handled pigs were moved at a moderate walking pace 3 times through a 50-m course and up and down a 15° loading ramp. Aggressively handled pigs were moved as fast as possible 3 times through the same course, but up and down a 30° ramp, and shocked 3 times with an electrical prod. Blood was collected immediately before and after handling in Exp. 1 and immediately after and 1 h after handling in Exp. 2. Feeding RAC increased (P < 0.01) ADG and G:F, but there was no effect (P > 0.10) of L-carnitine on growth performance. In Exp. 1 and 2, aggressive handling increased (P < 0.01) blood lactate dehydrogenase (LDH), lactate, cortisol, and rectal temperature and decreased blood pH. In Exp. 1, there was a RAC × handling interaction (P < 0.06) for the difference in pre- and posthandling blood pH and rectal temperature. Aggressively handled pigs fed RAC had decreased blood pH and increased rectal temperature compared with gently handled pigs, demonstrating the validity of the handling model. Pigs fed RAC had increased (P < 0.01) LDH compared with pigs not fed RAC. Pigs fed L-carnitine had increased (P < 0.03) lactate compared with pigs not fed L-carnitine. In Exp. 2, pigs fed RAC had lower (P < 0.02) blood pH immediately after handling, but pH returned to control levels by 1 h posthandling. Lactate, LDH, cortisol, and rectal temperature changes from immediately posthandling to 1 h posthandling were not different (P > 0.10) between pigs fed L-carnitine and those fed RAC, indicating that L-carnitine did not decrease recovery time of pigs subjected to aggressive handling. These results suggest that pigs fed 20 mg/kg of RAC are more susceptible to stress when handled aggressively compared with pigs not fed RAC. Dietary L-carnitine fed in combination with RAC did not alleviate the effects of stress. This research emphasizes the importance of using proper animal handling techniques when marketing finishing pigs fed RAC.


Asunto(s)
Agonistas Adrenérgicos beta/metabolismo , Carnitina/metabolismo , Manejo Psicológico , Fenetilaminas/metabolismo , Sus scrofa/fisiología , Agonistas Adrenérgicos beta/análisis , Alimentación Animal/análisis , Crianza de Animales Domésticos , Animales , Análisis Químico de la Sangre/veterinaria , Carnitina/análisis , Dieta/veterinaria , Suplementos Dietéticos/análisis , Femenino , Kansas , Masculino , Fenetilaminas/análisis , Estrés Fisiológico
13.
J Anim Sci ; 91(7): 3265-71, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23658355

RESUMEN

A total of 2,152 pigs (C22 × 336 PIC) were used in 4 experiments to determine the interactive effects of dietary l-carnitine and ractopamine HCl (RAC) on finishing pig growth performance. All trials were arranged as factorial arrangements with main effects of l-carnitine (0, 25, or 50 mg/kg in Exp. 1 and 2 and 0 or 50 mg/kg in Exp. 3 and 4) and RAC (0, 5, or 10 mg/kg in Exp. 1 and 0 or 10 mg/kg in Exp. 2, 3, and 4). Dietary carnitine was fed from 38 to 109 kg (Exp. 1 and 3) or for the last 4 or 3 wk before slaughter (118 kg; Exp. 2 and 4, respectively). Ractopamine HCl was fed for 4 wk (Exp. 1, 2, and 3) or 3 wk (Exp. 4) before slaughter. Experiments 1 and 2 were conducted in university research facilities, and Exp. 3 and 4 were conducted in a commercial research facility. All diets were formulated to contain 1.00% total Lys during the last phase of each experiment. In all experiments, pigs fed RAC had increased (P < 0.05) ADG and G:F compared with pigs fed no RAC. Feeding l-carnitine before the RAC feeding period did not affect pig growth performance. In Exp. 1 and 2, l-carnitine did not affect ADG during the last 4 wk; however, in Exp. 2, G:F tended (quadratic; P = 0.07) to improve with increasing l-carnitine. In Exp. 3, l-carnitine × RAC interactions were observed (P < 0.04) for ADG and G:F. Both added l-carnitine and RAC improved performance, but the response was not additive. In Exp. 4, pigs fed l-carnitine had increased (P < 0.04) ADG (0.88 vs. 0.84 kg) and G:F (0.36 vs. 0.35) compared with pigs fed no l-carnitine, and the response was additive to that of RAC. Analysis of treatments common to all experiments showed that pigs fed RAC had increased (P < 0.01) ADG (1.03 vs. 0.93 kg) and G:F (0.40 vs. 0.35) compared with pigs fed no RAC. Pigs fed l-carnitine tended to have increased (P = 0.07) ADG (1.00 vs. 0.96 kg) and improved (P < 0.01) G:F (0.38 vs. 0.37) compared with pigs not fed l-carnitine. These results confirm that RAC improves growth performance of finishing pigs. Added l-carnitine improved growth performance of finishing pigs, and the greatest response was observed in Exp. 3 and 4, which were conducted in commercial research environments. These experiments imply that adding l-carnitine to a finishing diet does not enhance the growth effects of RAC and that effects of RAC and l-carnitine on ADG and G:F are independent.


Asunto(s)
Agonistas Adrenérgicos beta/metabolismo , Carnitina/metabolismo , Fenetilaminas/metabolismo , Sus scrofa/fisiología , Complejo Vitamínico B/metabolismo , Aumento de Peso/efectos de los fármacos , Agonistas Adrenérgicos beta/administración & dosificación , Alimentación Animal/análisis , Fenómenos Fisiológicos Nutricionales de los Animales , Animales , Carnitina/administración & dosificación , Dieta/veterinaria , Suplementos Dietéticos/análisis , Relación Dosis-Respuesta a Droga , Femenino , Masculino , Fenetilaminas/administración & dosificación , Distribución Aleatoria , Sus scrofa/crecimiento & desarrollo , Complejo Vitamínico B/administración & dosificación
14.
J Anim Sci ; 91(7): 3272-82, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23422010

RESUMEN

Three experiments using 1,356 pigs (C22 × 336 PIC) were conducted to determine the interactive effects of dietary L-carnitine and ractopamine hydrochloride (RAC) on carcass characteristics and meat quality of finishing pigs. Experiments were arranged as factorials with main effects of L-carnitine and RAC; L-carnitine levels were 0, 25, or 50 mg/kg in Exp. 1 and 2 and 0 or 50 mg/kg in Exp. 3, and RAC levels of 0, 5, or 10 mg/kg in Exp. 1 and 0 or 10 mg/kg in Exp. 2 and 3. Dietary L-carnitine was fed from 38 kg to slaughter (109 and 118 kg in Exp. 1 and 3, respectively) or for 4 wk before slaughter (109 kg in Exp. 2). Ractopamine HCl was fed for 4 wk in all experiments. Exp. 1 and 2 were conducted at university research facilities (2 pigs per pen), and Exp. 3 was conducted in a commercial research barn (23 pigs per pen). In Exp. 1, an L-carnitine × RAC interaction (P < 0.02) was observed for LM visual color, L*, and a*/b*. In pigs fed RAC, increasing L-carnitine decreased L* and increased visual color scores and a*/b* compared with pigs not fed RAC. Ultimate pH tended to increase (linear, P < 0.07) with increasing L-carnitine. Drip loss decreased (linear, P < 0.04) in pigs fed increasing L-carnitine. In Exp. 2, firmness scores decreased in pigs fed increasing L-carnitine when not fed RAC, but firmness scores increased and drip losses decreased with increasing L-carnitine when RAC was added to the diet (L-carnitine × RAC interaction, P < 0.04). Percentage lean was greater (P < 0.01) for pigs fed RAC in Exp. 2. In Exp. 3, fat thickness decreased and lean percentage increased in pigs fed L-carnitine or RAC, but the responses were not additive (L-carnitine × RAC interaction, P < 0.03). Furthermore, pigs fed L-carnitine tended (P < 0.06) to have decreased LM drip loss percentage whereas pigs fed RAC had decreased (P < 0.05) 10th rib and average backfat and decreased drip loss than pigs fed diets without RAC. These results suggest that dietary RAC increased carcass leanness and supplemental L-carnitine reduced LM drip loss when fed in combination with RAC.


Asunto(s)
Agonistas Adrenérgicos beta/metabolismo , Composición Corporal/efectos de los fármacos , Carnitina/metabolismo , Carne/análisis , Fenetilaminas/metabolismo , Sus scrofa/fisiología , Complejo Vitamínico B/metabolismo , Agonistas Adrenérgicos beta/administración & dosificación , Alimentación Animal/análisis , Fenómenos Fisiológicos Nutricionales de los Animales , Animales , Carnitina/administración & dosificación , Dieta/veterinaria , Suplementos Dietéticos/análisis , Relación Dosis-Respuesta a Droga , Femenino , Masculino , Fenetilaminas/administración & dosificación , Distribución Aleatoria , Sus scrofa/crecimiento & desarrollo , Complejo Vitamínico B/administración & dosificación
15.
Pestic Biochem Physiol ; 107(1): 78-85, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-25149239

RESUMEN

Fluazifop-p-butyl (FL) is one of the most popular graminicides from arylophenoxypropionate group. These herbicides act as inhibitors of acetyl-CoA carboxylase (ACCase) that catalyzes the formation of malonyl-CoA during metabolism of lipids and/or of some secondary compounds. On the other hand arylopropionates and cyclohexanediones cause phytotoxic effects by stimulating free-radicals generation and causing oxidative stress in susceptible plants. However, the importance of disturbances in plant pigments and polyamines accumulation for this effect is not clear. The aim of this work is to quantify the phytotoxicity of FL to non target maize plant and to explain how photosynthetic pigments, anthocyanins (ANC) and polyamines participate in this interaction. Obtained results showed reduction of chlorophyll a and b, but only in case of the highest herbicide dose. Lower FL concentrations caused increase of the photosynthetic pigments, or were not effective. A similar effect was stated for putrescine, while spermidine was reduced within epicotyl of leaf tissues. In case of 2-phenylethylamine (PEA), there was observed a lack of significant changes within leaves and an increase in epicotyl under the middle and the highest dose of the herbicide. Moreover, FL induced ANC accumulation in epicotyls of maize seedlings. The activity of such key enzymes of polyamine biosynthesis as: ornithine decarboxylase (ODC) and lysine decarboxylase (LDC), increased in leaves treated with herbicide at the lowest concentration and decreased under the highest. However, in case of epicotyls the decreasing tendency was observed with the exception of ODC under the highest FL dose. The activity of tyrosine decarboxylase (TyDC) was importantly elevated only within epicotyls under the lower FL concentrations. It was concluded that FL inhibits maize growth, and the intensity of the effect is positively correlated with the herbicide concentration. The phenomenon was related to changes in content of pigments, polyamines and activity of studied enzymes.


Asunto(s)
Herbicidas/toxicidad , Piridinas/toxicidad , Zea mays/efectos de los fármacos , Antocianinas/metabolismo , Carboxiliasas/metabolismo , Carotenoides/metabolismo , Clorofila/metabolismo , Clorofila A , Fenetilaminas/metabolismo , Hojas de la Planta/efectos de los fármacos , Hojas de la Planta/crecimiento & desarrollo , Hojas de la Planta/metabolismo , Proteínas de Plantas/metabolismo , Poliaminas/metabolismo , Plantones/efectos de los fármacos , Plantones/crecimiento & desarrollo , Plantones/metabolismo , Zea mays/crecimiento & desarrollo , Zea mays/metabolismo
16.
Ther Drug Monit ; 32(5): 544-9, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20683389

RESUMEN

In recent years, besides the classic designer drugs of the amphetamine type, a series of new drug classes appeared on the illicit drugs market. The chemistry, pharmacology, toxicology, metabolism, and toxicokinetics is discussed of 2,5-dimethoxy amphetamines, 2,5-dimethoxy phenethylamines, beta-keto-amphetamines, phencyclidine derivatives as well as of herbal drugs, ie, Kratom. They have gained popularity and notoriety as rave drugs. The metabolic pathways, the involvement of cytochrome P450 isoenzymes in the main pathways, and their roles in hepatic clearance are also summarized.


Asunto(s)
Drogas de Diseño , Drogas Ilícitas , Trastornos Relacionados con Sustancias/metabolismo , Anfetaminas/química , Anfetaminas/metabolismo , Anfetaminas/farmacología , Animales , Cannabinoides/química , Cannabinoides/metabolismo , Cannabinoides/farmacología , Drogas de Diseño/química , Drogas de Diseño/metabolismo , Drogas de Diseño/farmacología , Medicamentos Herbarios Chinos/química , Medicamentos Herbarios Chinos/metabolismo , Medicamentos Herbarios Chinos/farmacología , Toxicología Forense/métodos , Humanos , Drogas Ilícitas/química , Drogas Ilícitas/metabolismo , Drogas Ilícitas/farmacología , Mitragyna , Fenciclidina/química , Fenciclidina/metabolismo , Fenciclidina/farmacología , Fenetilaminas/química , Fenetilaminas/metabolismo , Fenetilaminas/farmacología , Piperazinas/química , Piperazinas/metabolismo , Piperazinas/farmacología , Alcaloides de Triptamina Secologanina/química , Alcaloides de Triptamina Secologanina/metabolismo , Alcaloides de Triptamina Secologanina/farmacología , Detección de Abuso de Sustancias/métodos
17.
Eur J Pharmacol ; 430(1): 147-8, 2001 Oct 26.
Artículo en Inglés | MEDLINE | ID: mdl-11698075

RESUMEN

The pharmacological characteristics of [3H]dofetilide binding were examined in membranes prepared from human embryonic kidney (HEK293) cells stably expressing human ether-á-go-go related gene (HERG) K+ channels. The classIII antiarrhythmic compounds dofetilide, clofilium, 4'-[[1-[2-(6-methyl-2-pyridyl)ethyl]-4-piperidyl]carbonyl]methanesulfonanilide (E-4031), N-methyl-N-[2-[methyl-(1-methyl-1H-benzimidazol-2-yl)amino]ethyl]-4-[(methylsulfonyl)amino]benzene-sulfonamide (WAY-123,398) and d-sotalol all inhibited [3H]dofetilide binding. In addition, the structurally unrelated compounds pimozide, terfenadine and haloperidol, all of which prolong the QT interval in man, also inhibited binding. These data indicate that a [3H]dofetilide binding assay using HERG membranes may help identify compounds that prolong the QT interval.


Asunto(s)
Antiarrítmicos/metabolismo , Proteínas de Transporte de Catión , Membrana Celular/metabolismo , Proteínas de Unión al ADN , Fenetilaminas/metabolismo , Canales de Potasio con Entrada de Voltaje , Canales de Potasio/metabolismo , Sulfonamidas/metabolismo , Transactivadores , Bencimidazoles/farmacología , Unión Competitiva , Línea Celular , Evaluación Preclínica de Medicamentos/métodos , Canal de Potasio ERG1 , Electrocardiografía , Canales de Potasio Éter-A-Go-Go , Haloperidol/farmacología , Humanos , Técnicas de Placa-Clamp , Pimozida/farmacología , Bloqueadores de los Canales de Potasio , Canales de Potasio/genética , Compuestos de Amonio Cuaternario/farmacología , Sulfanilamidas/farmacología , Terfenadina/farmacología , Regulador Transcripcional ERG , Transfección , Tritio
18.
Am J Physiol Regul Integr Comp Physiol ; 279(2): R505-14, 2000 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-10938239

RESUMEN

The genetically, seasonally, and diet-induced obese, glucose-intolerant states in rodents, including ob/ob mice, have each been associated with elevated hypothalamic levels of norepinephrine (NE). With the use of quantitative autoradiography on brain slices of 6-wk-old obese (ob/ob) and lean mice, the adrenergic receptor populations in several hypothalamic nuclei were examined. The binding of [(125)I]iodocyanopindolol to beta(1)- and beta(2)-adrenergic receptors in ob/ob mice was significantly increased in the paraventricular hypothalamic nucleus (PVN) by 30 and 38%, in the ventromedial hypothalamus (VMH) by 23 and 72%, and in the lateral hypothalamus (LH) by 10 and 15%, respectively, relative to lean controls. The binding of [(125)I]iodo-4-hydroxyphenyl-ethyl-aminomethyl-tetralone to alpha(1)-adrenergic receptors was also significantly increased in the PVN (26%), VMH (67%), and LH (21%) of ob/ob mice. In contrast, the binding of [(125)I]paraiodoclonidine to alpha(2)-adrenergic receptors in ob/ob mice was significantly decreased in the VMH (38%) and the dorsomedial hypothalamus (17%) relative to lean controls. This decrease was evident in the alpha(2A)- but not the alpha(2BC)-receptor subtype. Scatchard analysis confirmed this decreased density of alpha(2)-receptors in ob/ob mice. Together with earlier studies, these changes in hypothalamic adrenergic receptors support a role for increased hypothalamic NE activity in the development of the metabolic syndrome of ob/ob mice.


Asunto(s)
Hipotálamo/metabolismo , Obesidad/genética , Obesidad/metabolismo , Receptores Adrenérgicos alfa/metabolismo , Receptores Adrenérgicos beta/metabolismo , Tetralonas , Animales , Autorradiografía , Clonidina/análogos & derivados , Clonidina/metabolismo , Femenino , Técnicas In Vitro , Yodocianopindolol/metabolismo , Ratones , Fenetilaminas/metabolismo , Valores de Referencia , Distribución Tisular
19.
Mol Pharmacol ; 51(4): 644-50, 1997 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-9106630

RESUMEN

Previous studies have shown that neural stimulation of brown adipose tissue (BAT) reorganizes the expression and activity of signaling proteins in the beta-adrenergic adenylyl cyclase pathway. Cold stress increases neural stimulation of BAT and increases alpha1-adrenergic receptor number; however, the alpha1 receptor subtype involved and the mechanism of up-regulation by cold stress have not been determined. Using reverse transcription/polymerase chain reaction analysis and nuclease protection assay, BAT was demonstrated to express mRNAs encoding alpha1a and alpha1d, but not alpha1b, receptors. Parallel pharmacologic studies of BAT membranes and recombinant alpha1a and alpha1d receptors expressed in COS-7 cells demonstrated that alpha1a receptors predominate in BAT. Exposure of rats to 4 degrees for 4 days increased alpha1a receptors and mRNA in BAT but did not alter expression of alpha1d receptors or mRNA. The induction of alpha1a receptor and mRNA level by cold stress was prevented by selective surgical denervation of BAT. Furthermore, alpha1a receptor and mRNA expression could be induced in warm-adapted rats by infusions of the selective beta3-adrenergic receptor agonist CL 316,243. These data indicate that neural activation of beta3-adrenergic receptors is an important determinant of alpha1a adrenergic receptor expression in BAT.


Asunto(s)
Tejido Adiposo Pardo/inervación , Tejido Adiposo Pardo/ultraestructura , Agonistas Adrenérgicos beta/farmacología , ARN Mensajero/metabolismo , Receptores Adrenérgicos alfa 1/metabolismo , Receptores Adrenérgicos beta/fisiología , Tetralonas , Tejido Adiposo Pardo/efectos de los fármacos , Antagonistas Adrenérgicos alfa/metabolismo , Antagonistas Adrenérgicos alfa/farmacología , Animales , Células COS/ultraestructura , Corteza Cerebral/metabolismo , ADN Complementario/genética , ADN Complementario/metabolismo , Dioxoles/farmacología , Estimulación Eléctrica , Radioisótopos de Yodo , Masculino , Fenetilaminas/metabolismo , Fenetilaminas/farmacología , Reacción en Cadena de la Polimerasa , ARN Mensajero/genética , Ensayo de Unión Radioligante , Ratas , Ratas Sprague-Dawley , Receptores Adrenérgicos alfa 1/clasificación , Receptores Adrenérgicos beta 3 , Sistema Nervioso Simpático/fisiología , Regulación hacia Arriba/fisiología
20.
Circ Res ; 79(1): 79-85, 1996 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-8925572

RESUMEN

Expression of cardiac transient outward current and inwardly rectifying K+ current is age dependent. However, little is known about age-related changes in cardiac delayed rectifier K+ current (IK, with rapidly and slowly activating components, IKr and IKs, respectively). Accordingly, the purpose of the present study was to assess developmental changes in IK channels in fetal, neonatal, and adult mouse ventricles. Three techniques were used: conventional microelectrode to measure the action potential, voltage clamp to record macroscopic currents of IK, and radioligand assay to examine [3H]dofetilide binding sites. The extent of prolongation of action potential duration at 95% repolarization (APD95) by a selective IKr blocker, dofetilide (1 mumol/L), dramatically decreased from fetal (137% +/- 18%) to day-1 (75% +/- 29%) and day-3 (20% +/- 15%) neonatal mouse ventricular tissues (P < .01). Dofetilide did not prolong APD95 in adult myocardium. IKr is the sole component of IK in day-18 fetal mouse ventricular myocytes. However, both IKr and IKs were observed in day-1 neonatal ventricular myocytes. With further development, IKs became the dominant component of IK in day-3 neonates. In adult mouse ventricular myocytes, neither IKr nor IKs was observed. Correspondingly, a high-affinity binding site for [3H]dofetilide was present in fetal mouse ventricles but was absent in adult ventricles. The complementary data from microelectrode, voltage-clamp, and [3H]dofetilide binding studies demonstrate that expression of the IK channel is developmentally regulated in the mouse heart.


Asunto(s)
Envejecimiento/fisiología , Miocardio/metabolismo , Canales de Potasio/fisiología , Potenciales de Acción , Animales , Antiarrítmicos/metabolismo , Sitios de Unión , Ratones , Ratones Endogámicos , Miocardio/citología , Fenetilaminas/metabolismo , Sulfonamidas/metabolismo , Función Ventricular
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA